Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

In 2020, an expert consensus developed an initial framework for remission in asthma that includes a sustained absence of ...

Data were obtained from electronic patient records. Rates of treatment with oral corticosteroids (OCS) and/or antibiotics were collected during routine asthma follow-up and used as surrogates for ...

Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

are also being prescribed as daily controller medications and for treatment of asthma flares. AirSupra (albuterol and budenoside) is also used for this purpose and has been shown to reduce severity of ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

Background Evidence regarding high-dose inhaled corticosteroids (HDICS) in asthma exacerbations in adults is insufficient. This study compares the treatment outcomes of HDICS as add-on therapy to the ...